Gyre Therapeutics, Inc. Property, Plant and Equipment, Gross
Gyre Therapeutics, Inc. (GYRE) had Property, Plant and Equipment, Gross of $39.98 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-08-07
- 2026-06-30: Property, Plant and Equipment, Gross $39.98M.
- 2026-03-31: Property, Plant and Equipment, Gross $31.74M.
- 2025-12-31: Property, Plant and Equipment, Gross $38.55M; Property, Plant and Equipment, Gross as first filed $31.18M.
- 2025-09-30: Property, Plant and Equipment, Gross $30.54M.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2026-06-30 | $39.98M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $31.74M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $38.55M 10-Q · filed 2026-08-07 | $31.18M 10-K · filed 2026-03-13 |
| 2025-09-30 | $30.54M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $29.83M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $29.59M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $29.48M 10-K · filed 2026-03-13 | |
| 2024-09-30 | $29.77M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $28.48M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $28.24M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $27.55M 10-K · filed 2025-03-17 | |
| 2022-12-31 | $21.71M 10-K · filed 2024-03-27 | |
| 2018-12-31 | $671.00K 10-K · filed 2019-03-08 | |
| 2017-12-31 | $2.30M 10-K · filed 2019-03-08 | |
| 2016-12-31 | $2.30M 10-K · filed 2018-03-19 | |
| 2015-12-31 | $6.40M 10-K · filed 2017-03-08 | |
| 2014-12-31 | $7.56M 10-K · filed 2016-03-09 | $2.10M 10-K · filed 2015-03-16 |
| 2013-12-31 | $8.63M 8-K/A · filed 2015-10-23 | $2.56M 10-K · filed 2014-03-14 |
| 2012-12-31 | $5.51M 10-K · filed 2014-03-14 | |
| 2011-12-31 | $17.87M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |